28242166|t|Dysphagia -optimised Intensity-modulated Radiotherapy Techniques in Pharyngeal Cancers: Is Anyone Going to Swallow it?
28242166|a|Dysphagia after primary chemoradiotherapy or radiation alone in pharyngeal cancers can have a devastating impact on a patient's physical, social and emotional state. Establishing and validating efficient dysphagia - optimised radiotherapy techniques is, therefore, of paramount importance in an era where health-related quality of life measures are increasingly influential determinants of curative management strategies, particularly as the incidence of good prognosis, human papillomavirus -driven pharyngeal cancer in younger patients continues to rise. The preferential sparing achievable with intensity-modulated radiotherapy (IMRT) of key swallowing structures implicated in post-radiation dysfunction, such as the pharyngeal constrictor muscles (PCM), has generated significant research into toxicity - mitigating strategies. The lack of randomised evidence, however, means that there remains uncertainty about the true clinical benefits of the dosimetric gains offered by technological advances in radiotherapy. As a result, we feel that IMRT techniques that spare PCM cannot be incorporated into routine practice. In this review, we discuss the swallowing structures responsible for functional impairment, analyse the studies that have explored the dose-response relationship between these critical structures and late dysphagia, and consider the merits of reported dysphagia - optimised IMRT (Do-IMRT) approaches, thus far. Finally, we discuss the dysphagia / aspiration -related structures (DARS) study (ISRCTN 25458988), which is the first phase III randomised controlled trial designed to investigate the impact of swallow -sparing strategies on improving long-term function. To maximise patient benefits, improvements in radiation delivery will need to integrate with novel treatment paradigms and comprehensive rehabilitation strategies to eventually provide a patient -centric, personalised treatment plan.
28242166	0	9	Dysphagia	T047	C0011168
28242166	21	53	Intensity-modulated Radiotherapy	T061	C1512814
28242166	54	64	Techniques	T169	C0449851
28242166	68	86	Pharyngeal Cancers	T191	C0153405
28242166	119	128	Dysphagia	T047	C0011168
28242166	143	160	chemoradiotherapy	T061	C0436307
28242166	164	173	radiation	T070	C0851346
28242166	183	201	pharyngeal cancers	T191	C0153405
28242166	225	231	impact	T080	C4049986
28242166	237	246	patient's	T101	C0030705
28242166	247	255	physical	T080	C0597240
28242166	257	263	social	T169	C0728831
28242166	268	283	emotional state	T041	C0935620
28242166	313	322	efficient	T080	C0442799
28242166	323	332	dysphagia	T047	C0011168
28242166	335	344	optimised	T052	C2698650
28242166	345	368	radiotherapy techniques	T061	C1522449
28242166	424	454	health-related quality of life	T078	C4279947
28242166	455	463	measures	T081	C0079809
28242166	468	480	increasingly	T169	C0442808
28242166	493	505	determinants	T169	C1521761
28242166	509	539	curative management strategies	T170	C0679716
28242166	561	570	incidence	T081	C0021149
28242166	579	588	prognosis	T058	C0033325
28242166	590	610	human papillomavirus	T005	C0021344
28242166	619	636	pharyngeal cancer	T191	C0153405
28242166	640	647	younger	T079	C0332239
28242166	648	656	patients	T101	C0030705
28242166	717	749	intensity-modulated radiotherapy	T061	C1512814
28242166	751	755	IMRT	T061	C1512814
28242166	764	785	swallowing structures	T040	C0011167
28242166	800	826	post-radiation dysfunction	T077	C3887504
28242166	840	870	pharyngeal constrictor muscles	T023	C0224205
28242166	872	875	PCM	T023	C0224205
28242166	892	903	significant	T078	C0750502
28242166	904	912	research	T062	C0035168
28242166	918	926	toxicity	T080	C0040539
28242166	929	939	mitigating	T067	C1553901
28242166	964	974	randomised	T080	C0439605
28242166	975	983	evidence	T078	C3887511
28242166	1046	1054	clinical	T080	C0205210
28242166	1055	1063	benefits	T081	C0814225
28242166	1071	1081	dosimetric	T059	C0034603
28242166	1082	1087	gains	T081	C1517378
28242166	1099	1121	technological advances	UnknownType	C0681519
28242166	1125	1137	radiotherapy	T061	C1522449
28242166	1165	1169	IMRT	T061	C1512814
28242166	1170	1180	techniques	T169	C0449851
28242166	1192	1195	PCM	T023	C0224205
28242166	1273	1294	swallowing structures	T040	C0011167
28242166	1311	1332	functional impairment	T033	C4062321
28242166	1377	1403	dose-response relationship	T038	C0678790
28242166	1418	1437	critical structures	T033	C0243095
28242166	1447	1456	dysphagia	T047	C0011168
28242166	1494	1503	dysphagia	T047	C0011168
28242166	1506	1515	optimised	T052	C2698650
28242166	1516	1520	IMRT	T061	C1512814
28242166	1522	1529	Do-IMRT	T061	C1512814
28242166	1577	1586	dysphagia	T047	C0011168
28242166	1589	1599	aspiration	T046	C0700198
28242166	1609	1632	structures (DARS) study	T062	C2603343
28242166	1665	1680	first phase III	T079	C0205390
28242166	1681	1708	randomised controlled trial	T062	C0206035
28242166	1737	1743	impact	T080	C4049986
28242166	1747	1754	swallow	T169	C1706486
28242166	1778	1787	improving	T080	C1272745
28242166	1788	1797	long-term	T079	C0443252
28242166	1798	1806	function	T169	C0542341
28242166	1820	1836	patient benefits	T058	C0509803
28242166	1838	1850	improvements	T077	C2986411
28242166	1854	1872	radiation delivery	T061	C2094475
28242166	1907	1916	treatment	T061	C0087111
28242166	1917	1926	paradigms	T062	C0681797
28242166	1931	1959	comprehensive rehabilitation	T169	C0034992
28242166	1995	2002	patient	T101	C0030705
28242166	2013	2040	personalised treatment plan	T170	C0599880